Skip to main content

Table 1 Baseline patient characteristics given in absolute number and percentage

From: Class-switched B cells display response to therapeutic B-cell depletion in rheumatoid arthritis

Baseline patient characteristic Absolute number Percentage
Gender distribution (female) 30/35 85%
RF-positive 21/35 60%
CCP antibody-positive 21/35 60%
RF- and anti-CCP-positive 18/35 54%
Erosive disease 26/35 74%
Extra-articular manifestations 6/35 17% Age at disease onset, years 38a  
Age at inclusion, years 55a  
Disease duration at inclusion, months 108a  
Number of previous DMARDs 2.9b  
Number of previous anti-TNF agents 1.6b  
Concurrent MTX alone 22 63%
DMARD combination including MTX 2 6%
Leflunomide 4 11%
Prednisone dose, mg/day 10a  
  1. aThe median value is presented. bThe mean value is presented. CCP, cyclic citrullinated peptide; DMARD, disease-modifying antirheumatic drug; MTX, methotrexate; RF, rheumatoid factor; TNF, tumour necrosis factor.